News Focus
News Focus
Followers 13
Posts 853
Boards Moderated 0
Alias Born 01/09/2018

Re: AlwaysIntheKnow post# 11282

Thursday, 03/30/2023 2:59:30 PM

Thursday, March 30, 2023 2:59:30 PM

Post# of 15168
Key point though Wave in the press release is that the last two batches they tested weren't needed for FDA approval. If you remember, they produced batch one which matched up identically with clinical trials. That is what they needed for approval from my understanding. It seems they are doing more testing to not only make the company more attractive but give them insurance if the company needs to produce the product for a quarter. To take business away to increase offers. I stress, they have produced a batch that matched up identically with clinical trials. So a buying company would have to make sure mass production worked. It looks like they want mass production to work under their watch to give them more options.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UEEC News